BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/26/2014 1:51:00 PM | Browse: 1113 | Download: 872
Publication Name World Journal of Gastroenterology
Manuscript ID 7752
Country Austria
Received
2013-11-30 13:01
Peer-Review Started
2013-12-02 16:54
To Make the First Decision
2014-01-09 18:35
Return for Revision
2014-01-20 21:54
Revised
2014-02-07 20:08
Second Decision
2014-03-13 16:19
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2014-03-13 16:30
Articles in Press
2014-05-23 11:01
Publication Fee Transferred
Edit the Manuscript by Language Editor
2014-03-21 17:30
Typeset the Manuscript
2014-06-13 13:59
Publish the Manuscript Online
2014-06-27 10:37
ISSN 1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Topic Highlights
Article Title Epigenetics and pancreatic cancer: Pathophysiology and novel treatment aspects
Manuscript Source Invited Manuscript
All Author List Daniel Neureiter, Tarkan Jäger, Matthias Ocker and Tobias Kiesslich
Funding Agency and Grant Number
Corresponding Author Daniel Neureiter, MD, MA, Institute of Pathology, Paracelsus Medical University/Salzburger Landeskliniken (SALK), Muellner Hauptstrasse 48, 5020 Salzburg, Austria. d.neureiter@salk.at
Key Words Pancreatic cancer; Epigenetics; DNA methylation; Histone modification; microRNA; Targeted therapy; Epithelial-mesenchymal transition
Core Tip Pancreatic cancer represents a devastating disease with poor overall survival at advanced stages, and new and effective treatment options are required. Besides genetic mutations, epigenetic dysregulation of oncogenes and tumor suppressor genes is recognized as a novel therapeutic target. Mechanisms underlying DNA methylation, histone acetylation and microRNA regulation and their contribution to pancreatic cancer development and resistance to treatment are highlighted in this review. Potential therapeutic interventions are discussed.
Publish Date 2014-06-27 10:37
Citation Neureiter D, Jäger T, Ocker M, Kiesslich T. Epigenetics and pancreatic cancer: Pathophysiology and novel treatment aspects. World J Gastroenterol 2014; 20(24): 7830-7848
URL http://www.wjgnet.com/1007-9327/full/v20/i24/7830.htm
DOI http://dx.doi.org/10.3748/wjg.v20.i24.7830
Full Article (PDF) WJG-20-7830.pdf
Full Article (Word) WJG-20-7830.doc
Manuscript File 7752-Review.docx
Answering Reviewers 7752-Answering reviewers.pdf
Copyright License Agreement 7752-Copyright assignment.pdf
Peer-review Report 7752-Peer review(s).pdf
Scientific Editor Work List 7752-Scientific editor work list.doc